Review Article

Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option

Table 1

Demographic and clinical features at enrollment in clinical trials.

SourceYearCountryNumber of enrolled patientsAge (year)DiseaseCauses of diseaseType of cellsRoute of administrationFollow-up (month)Assessments

Pan et al.2008China1018–27LFNABMSCHepatic/splenic artery3ALT, AST, PT, TBIL, DBIL, ALB, fibrinogen
Khan et al.2008India4NACLFHBV:1, HCV:3BMMSCHepatic arteryNAALB, BILALT, Child score, MELD
Peng et al.2011ChinaBMSC:53, control:105BMSC: 42.19 ± 10.8; control: 42.22 ± 11.37CLFHBVBMMSCHepatic artery48ALT, TBIL, PT, ALB, MELD
Amer et al.2011EgyptBMSC: 20, control: 20BMSC: 50.5 ± 4.1, control: 55 ± 3.6CLFHCVBMHCNA6Child score, MELD
Shi et al.2012ChinaUCMSC: 24, control: 19UCMSC: 40, control: 45ACLFHBVUCMSCCubital vein of the arm18ALT, TBIL, ALB, CHE, PTA, MELD
Park et al.2013Korea544 ± 7.07LFHBV: 2, HCV: 2, other 1BMMNCHepatic artery12ALT, Cr, INR, CT, Child scores, QoL
Wan et al.2013ChinaACLF: 30, control: 20ACLF: 43, control: 39ACLFHBVHSCNANAALT, TIBL, Cr, IL-6, MMP-2/9, Ishak score, Child class, MELD
Li et al.2016ChinaUCMSC + PE: 11, PE: 34UCMSC + PE: 51.1 ± 11.2, PE: 50.0 ± 10.9ACLFHBVUCMSCHepatic artery24ALT, AST, DBIL, TBIL, Cr, DBIL, PT, INR, AFP, MELD, USG, CT
Lin et al.2017ChinaBMSC: 56, control: 54BMMSC: 40.04 ± 9.94, control: 42.78 ± 8.40ACLFHBVBMMSCPeripheral veins6ALB, ALT, TBIL, INR, CT, MRI, US, Cr, MELD

Data are expressed as mean ± standard deviation. NA: not available; ACLF: acute-on-chronic liver failure; UCMSC: umbilical cord-derived mesenchymal stem cell; BMSC: bone marrow-derived mesenchymal stromal cell; HSC: hematopoietic stem cell; ALB: albumin; ALT: alanine aminotransferase; AST: aspartate transaminase; TBIL: total bilirubin; DBIL: direct bilirubin; PT: prothrombin time; INR: international normalized ratio; Cr: creatinine; MELD: model for end-stage liver disease score; QoL: quality of life; CT: computed tomography scan: MRI: magnetic resonance imaging; US: ultrasonography.